Alosa Health News

FDA Review Process Speedier than European Counterpart

Posted in News on 4.6.2017

The FDA has been getting flack from the U.S. President as well as the president’s nominee to lead the agency, Dr. Scott Gottlieb, on account of their approvals process, which has been characterized as “slow and burdensome”. Yet, a recent study published in the New England Journal of Medicine (NEJM) revealed that the FDA approved …

Proposed NIH Cuts Would Inhibit Medical Research

Posted in News on 3.30.2017

The current iteration of the federal budget proposed by the U.S. President would cut $1.2 billion to the National Institutes of Heath (NIH), though the budget needs to be approved in both houses of Congress before it can go into effect and thus modifications are possible. The cuts target research grant funding, which would substantially …

Ulterior Motive in Question with Drug Companies’ Charity

Posted in News on 2.16.2017

The Massachusetts U.S. Attorney’s Office is currently leading a nationwide  investigation into drug companies’ charitable contributions toward organizations that provide financial assistance to patients whose health conditions require expensive drugs. These organizations typically cover copayments, alleviating the financial responsibility of patients, while Medicare covers the rest of the cost. Drug companies may appear to be …

Congress Says ‘Yes’ to Fast Track FDA Approvals

Posted in News on 12.9.2016

Last week Congress passed legislation addressing questions of healthcare regulation and public health funding. The 21st Century Cures Bill was able to gain easy approval in both the House and Senate because it contains provisions that appeal to both sides of the aisle and to various industry and public interest groups. One of the most …

Bill to Ease FDA Approval Draws Praise and Rebuke

Posted in News on 12.1.2016

Alosa Health founder Dr. Jerry Avorn was quoted in the Wall Street Journal regarding a healthcare bill scheduled for a vote in the House next week. The bill in question covers a breadth of topics from funding for biomedical research to opioid addiction to the FDA’s regulatory processes.  The proposal to ease FDA standards for …

Healthcare Bill to Fund Research, Overhaul FDA Regs

Posted in News on 11.30.2016

The $6.3 billion bill that has been called “parting gift” to Vice President Joe Biden contains a smorgasbord of healthcare related provisions, including a commitment to additional funding for cancer research through the National Institutes of Health (NIH). Notably, Biden’s son died of brain cancer last year. Other topics that the bill touches on include …